论文信息 - Abstract 5580: Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression - 字舞流文

Abstract 5580: Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression

James D. Clarke | M. Congreve | J. Mason | F. Marshall | P. Lyne | C. Reimer | N. Deng | Nicole Strittmatter | K. Sachsenmeier | V. Sah | R. Woessner | A. Borodovsky | R. Goodwin | A. Fretland | D. Lawson | M. Ye | Yanjun Wang | J. Shaw | Carl M. Hay | Kelly J. DelSignore